The FINANCIAL — Bayer HealthCare has launched the flea- and tick-collar Seresto for cats and dogs in the U.S.-market.
The innovative collar consists of a patented polymermatrix which releases a combination of the proven active ingredients imidacloprid and flumethrin in controlled, very low doses, maintaining the necessary level of active ingredient. As Bayer AG said, this gives a continuous eight months protection against fleas and ticks in cats and dogs. With Seresto Bayer provides for the first time ever a cat-product to repel ticks, which means that ticks cannot attach to the cat, and therefore minimize the risk of tick transmitted diseases.
“With Seresto, we are now happy to offer an effective long-term protection for cats and dogs also in the U.S.”, says Dr Dirk Ehle, Head of Bayer HealthCare’s Animal Health division. “This nicely complements our parasiticide product portfolio with monthly application. Pet owners now have the choice which treatment is best and most convenient for them and their pet against fleas and ticks.”
According to market studies, pet owners tend to forget to re-apply the monthly treatment on schedule which results in a lack of protection until the product is used again. This gap does not occur when using the long-term collar due to its special release mechanism.